- US-listed companies
- FILANA THERAPEUTICS, INC.
- Balance sheet
FILANA THERAPEUTICS, INC.【FLNA】Balance sheet
Market cap
$106.76M
P/E ratio
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Cash and cash equivalents | 73 | 49 | 49 | 41 | 31 | 17 | 10 | 20 | 23 | 94 | 233 | 201 | 121 | 129 |
| Marketable securities, current | 25 | 7 | 1 | - | - | 2 | - | - | - | - | - | - | - | - |
| Total cash & short-term investments | 98 | 56 | 50 | 41 | 31 | 19 | 10 | 20 | 23 | 94 | 233 | 201 | 121 | 129 |
| Total current assets | 98 | 57 | 50 | 41 | 32 | 19 | 11 | 20 | 23 | 94 | 244 | 211 | 130 | 137 |
| Property, plant and equipment, net | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21 | 23 | 22 | 21 |
| Total non-current assets | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 22 | 24 | 22 | 21 |
| Total assets | 99 | 57 | 50 | 41 | 32 | 19 | 11 | 20 | 23 | 94 | 267 | 235 | 152 | 158 |
| Accounts payable | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 7 | 4 | - | - |
| Total current liabilities | 13 | 10 | 2 | 1 | 3 | 1 | 1 | 1 | 1 | 2 | 13 | 7 | 14 | 12 |
| Total non-current liabilities | 41 | 34 | - | - | - | - | - | - | - | 0 | 0 | 0 | - | 0 |
| Total liabilities | 55 | 44 | 2 | 1 | 3 | 1 | 1 | 1 | 1 | 2 | 13 | 7 | 14 | 12 |
| Common stock and paid-in capital | 176 | 149 | 152 | 157 | 160 | 164 | 167 | 184 | 191 | 267 | 461 | 511 | 518 | 551 |
| Retained earnings | -132 | -136 | -104 | -116 | -131 | -145 | -157 | -164 | -169 | -175 | -207 | -284 | -381 | -405 |
| Stockholders' equity | 44 | 13 | 48 | 40 | 29 | 19 | 10 | 20 | 22 | 92 | 254 | 228 | 137 | 146 |